链激酶：其临床药理学、作用机制及治疗用途综述 - Suppr

Suppr

超能文献

Streptokinase: a review of its clinical pharmacology, mechanism of action and therapeutic uses.

作者信息

Brogden R N, Speight T M, Avery G S

出版信息

Drugs. 1973;5(5):357-445. doi: 10.2165/00003495-197305050-00002.

DOI:10.2165/00003495-197305050-00002

PMID:4580461

Abstract

摘要

相似文献

Streptokinase: a review of its clinical pharmacology, mechanism of action and therapeutic uses.链激酶：其临床药理学、作用机制及治疗用途综述

Drugs. 1973;5(5):357-445. doi: 10.2165/00003495-197305050-00002.

[Fibrinolytics. 46].[纤维蛋白溶解剂。46]。

Pharm Prax. 1970;6:141-2.

[Streptokinase or urokinase: the elements of choice].链激酶或尿激酶：首选药物

Haemostasis. 1986;16 Suppl 4:21-5. doi: 10.1159/000215528.

[Therapeutic fibrinolysis].[治疗性纤维蛋白溶解]

Schweiz Med Wochenschr. 1973 May 19;103(20):753-7.

Current developments in thrombolytic therapy.溶栓治疗的当前进展。

Thromb Diath Haemorrh Suppl. 1973;56:201-10.

[Thrombolytic treatment].[溶栓治疗]

Rev Prat. 1977 Dec 11;27(57):4009-17.

Fibrinolytic therapy.纤维蛋白溶解疗法。

Compr Ther. 1976 Apr;2(4):67-73.

The use of fibrinolytic agents.纤维蛋白溶解剂的使用。

West J Med. 1981 Feb;134(2):128-33.

[When is fibrinolytic therapy indicated?].[何时适合进行纤溶治疗？]

Med Klin. 1980 Feb 1;75(3):98-107.

[Thrombolytic therapy. I. Introduction and principles of therapy. Indications. Contraindications. Schematics of the treatment].[溶栓治疗。I. 治疗的介绍与原则。适应证。禁忌证。治疗示意图]

Przegl Lek. 1969;25(8):565-8.

引用本文的文献

Efficacy of an organophosphorus hydrolase enzyme (OpdA) in human serum and minipig models of organophosphorus insecticide poisoning.有机磷水解酶（OpdA）在人血清和小型猪有机磷农药中毒模型中的疗效。

Clin Toxicol (Phila). 2020 May;58(5):397-405. doi: 10.1080/15563650.2019.1655149. Epub 2019 Aug 27.

Fibrinolytic therapy in patients with ST-segment elevation myocardial infarction: Accelerated versus standard Streptokinase infusion regimen.ST段抬高型心肌梗死患者的纤溶治疗：加速与标准链激酶输注方案对比

J Cardiovasc Thorac Res. 2017;9(4):209-214. doi: 10.15171/jcvtr.2017.36. Epub 2017 Dec 30.

Ionic modulation of the effects of heparin and 6-aminohexanoic acid on plasminogen activation by streptokinase: the role of ionic strength, divalent cations and chloride.肝素和6-氨基己酸对链激酶激活纤溶酶原作用的离子调节：离子强度、二价阳离子和氯离子的作用

Eur J Drug Metab Pharmacokinet. 2003 Apr-Jun;28(2):161-6. doi: 10.1007/BF03190506.

Thrombolytic therapy in acute myocardial infarction.急性心肌梗死的溶栓治疗。

Drugs Aging. 2000 Apr;16(4):301-12. doi: 10.2165/00002512-200016040-00006.

Streptokinase. A review of its pharmacology and therapeutic efficacy in acute myocardial infarction in older patients.链激酶。老年患者急性心肌梗死中其药理学及治疗效果的综述

Drugs Aging. 1994 Jan;4(1):63-86. doi: 10.2165/00002512-199404010-00007.

Fibrinolytic treatment of thrombus on prosthetic heart valves.人工心脏瓣膜上血栓的纤溶治疗。

Br Heart J. 1980 Nov;44(5):545-54. doi: 10.1136/hrt.44.5.545.

Anisoylated plasminogen streptokinase activator complex (APSAC). A review of its mechanism of action, clinical pharmacology and therapeutic use in acute myocardial infarction.茴香酰化纤溶酶原链激酶激活剂复合物（APSAC）。对其作用机制、临床药理学及在急性心肌梗死中的治疗应用的综述。

Drugs. 1987 Jul;34(1):25-49. doi: 10.2165/00003495-198734010-00002.

Thrombolytic treatment and new calcium antagonists.溶栓治疗与新型钙拮抗剂。

Br Med J (Clin Res Ed). 1988 Mar 5;296(6623):705-8. doi: 10.1136/bmj.296.6623.705.

Use of thrombolytic drugs in non-coronary disorders.溶栓药物在非冠状动脉疾病中的应用。

Drugs. 1989 Nov;38(5):801-21. doi: 10.2165/00003495-198938050-00006.

Intravenous streptokinase. A reappraisal of its therapeutic use in acute myocardial infarction.静脉注射链激酶。对其在急性心肌梗死治疗中的应用重新评估。

Drugs. 1990 May;39(5):693-719. doi: 10.2165/00003495-199039050-00006.

本文引用的文献

STREPTOCOCCAL FIBRINOLYSIS: A PROTEOLYTIC REACTION DUE TO A SERUM ENZYME ACTIVATED BY STREPTOCOCCAL FIBRINOLYSIN.链球菌纤维蛋白溶解：一种由于链球菌纤维蛋白溶酶激活的血清酶引起的蛋白水解反应。

J Gen Physiol. 1945 Mar 20;28(4):363-83. doi: 10.1085/jgp.28.4.363.

THE FIBRINOLYTIC ACTIVITY OF HEMOLYTIC STREPTOCOCCI.溶血链球菌的纤溶活性。

J Exp Med. 1933 Sep 30;58(4):485-502. doi: 10.1084/jem.58.4.485.

The lysis in rabbits of intravascular blood clots by the streptococcal fibrinolytic system (streptokinase).链球菌纤维蛋白溶解系统（链激酶）对兔血管内血栓的溶解作用。

J Exp Med. 1952 May 1;95(5):449-64. doi: 10.1084/jem.95.5.449.

Anticoagulant therapy in occlusive vascular disease of the retina.视网膜闭塞性血管疾病的抗凝治疗

AMA Arch Ophthalmol. 1951 Dec;46(6):601-17. doi: 10.1001/archopht.1951.01700020615001.

An unusual case of central retinal vein occlusion, treated successfully with intravenous fibrinolysin.一例罕见的视网膜中央静脉阻塞病例，经静脉注射纤维蛋白溶酶成功治愈。

Can Med Assoc J. 1961 Oct 7;85(15):844-6.

Proactivator function of human plasmin as shown by lysine esterase assay.通过赖氨酸酯酶测定显示的人纤溶酶的前激活剂功能。

J Biol Chem. 1961 Oct;236:2807-12.

Prevention of venous thrombosis and pulmonary embolism in injured patients. A trial of anticoagulant prophylaxis with phenindione in middle-aged and elderly patients with fractured necks of femur.创伤患者静脉血栓形成和肺栓塞的预防。一项针对中老年股骨颈骨折患者使用苯茚二酮进行抗凝预防的试验。

Lancet. 1959 Dec 5;2(7110):981-9. doi: 10.1016/s0140-6736(59)91464-3.

The lysis of artificially induced intravascular clots in man by intravenous infusions of streptokinase.通过静脉输注链激酶对人体人工诱导的血管内血栓进行溶解。

J Clin Invest. 1959 Sep;38(9):1627-43. doi: 10.1172/JCI103941.

The successful treatment of a case of central retinal vein thrombosis with intravenous fibrinolysin.1例视网膜中央静脉阻塞患者经静脉注射纤维蛋白溶酶治疗成功。

Can Med Assoc J. 1959 Sep 1;81(5):382-4.

Treatment of cerebrovascular thrombosis with fibrinolysin. Preliminary report.用纤维蛋白溶酶治疗脑血管血栓形成。初步报告。

Am J Cardiol. 1960 Aug;6:540-5. doi: 10.1016/0002-9149(60)90350-7.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验